Injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved; Injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved; Headache beginning at 12 hours persisted for 48 hours but has resolved.; Malaise beginning at 12 hours has resolved within 60 hours; Vertigo beginning at 12 hours has been steadily increasing in severity; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 25Aug2021 17:00 (Lot number: FF2588) at the age of 43 years as dose 2,single for covid-19 immunisation. Relevant medical history included: "Migraine" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "known allergies: Penicillan" (unspecified if ongoing). Concomitant medication(s) included: FLEXERIL [CEFIXIME]; AMITRIPTYLINE; RELPAX; LEVOTHYROXINE. Vaccination history included: Bnt162b2 (lot number: FA7485, dose number: 1 single, vaccine location: right arm), administration date: 04Aug2021, when the patient was 43 years old, for COVID-19 immunisation.  The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset 26Aug2021 18:00, outcome "recovered" (2021) and all described as "Injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved"; HEADACHE (non-serious) with onset 26Aug2021 05:00, outcome "recovered" (28Aug2021 05:00), described as "Headache beginning at 12 hours persisted for 48 hours but has resolved."; MALAISE (non-serious) with onset 26Aug2021 05:00, outcome "recovered" (2021), described as "Malaise beginning at 12 hours has resolved within 60 hours"; VERTIGO (non-serious) with onset 26Aug2021 05:00, outcome "not recovered", described as "Vertigo beginning at 12 hours has been steadily increasing in severity". The events "injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved", "injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved", "headache beginning at 12 hours persisted for 48 hours but has resolved.", "malaise beginning at 12 hours has resolved within 60 hours" and "vertigo beginning at 12 hours has been steadily increasing in severity" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of vaccination site pain, vaccination site warmth, headache, malaise, vertigo.   Additional Information: Injections site pain that radiated to hand and heat at injection site occurred at 48 hours but has since resolved. Headache beginning at 12 hours persisted for 48 hours but has resolved. Malaise beginning at 12 hours has resolved within 60 hours. Vertigo beginning at 12 hours has been steadily increasing in severity. Patient had not covid prior to the vaccination and the patient had not covid tested post vaccination. No follow-up attempts are possible. No further information is expected.